The Estrogen Receptor α-Cistrome Beyond Breast Cancer

Area of Science:

• Endocrinology
• Molecular Biology
• Genomics

Background:

• Estrogen receptor (ER)α is expressed in many tissues, but its DNA-binding sites (cistrome) are primarily studied in breast cancer.
• ERα occupies only a small fraction of potential binding sites in breast cancer, raising questions about its broader genomic interactions.
• Factors like ligands, splice variants, and mutations influence ERα conformation and chromatin interactions.

Purpose of the Study:

• To review biological variables influencing ERα cistromics across different tissues.
• To assess the translatability of ERα genomics from breast cancer to other tissue types.

Main Methods:

• Literature review of studies on human specimens, cell lines, and mouse tissues.
• Analysis of ERα cistrome data in breast, endometrium, liver, and bone.
• Discussion of factors affecting ERα-chromatin interactions, including chromosomal boundaries and cell-type-specific proteomes.

Main Results:

• ERα predominantly binds to enhancers in studied tissues.
• Chromosomal boundaries create distinct regulatory regions with variable enhancer usage across tissues.
• Cell-type-specific proteomes dictate ERα interactions with enhancers and transcriptional machinery.

Conclusions:

• ERα cistromics are influenced by a complex interplay of biological variables.
• The specific genomic binding of ERα is context-dependent and differs significantly between tissues.
• Direct translation of ERα genomics from breast cancer to other tissues may be limited due to tissue-specific regulatory mechanisms.